rs1554085382
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.3901dupA(p.Thr1301AsnfsTer14) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000038.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.3901dupA | p.Thr1301AsnfsTer14 | frameshift_variant | Exon 16 of 16 | 5 | NM_000038.6 | ENSP00000257430.4 | ||
ENSG00000258864 | ENST00000520401.1 | n.228+10523dupA | intron_variant | Intron 3 of 7 | 3 | ENSP00000454861.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
- -
The c.3901dupA variant, located in coding exon 15 of the APC gene, results from a duplication of A at nucleotide position 3901, causing a translational frameshift with a predicted alternate stop codon (p.T1301Nfs*14). This alteration occurs at the 3' terminus of the APC gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 54% of the protein. However, premature stop codons are typically deleterious in nature. This variant has been reported in a familial adenomatous polyposis cohort Gismondi V et al. Hum Mutat, 1997;9:370-3). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Familial multiple polyposis syndrome Pathogenic:1
Variant summary: APC c.3901dupA (p.Thr1301AsnfsX14) results in a premature termination codon, predicted to cause a truncation of the encoded protein, and at-least one downtream frameshifting variant has been evaluated PATH (c.4393_4394dupAG p.Ser1465ArgfsX9). The variant was absent in 250960 control chromosomes. c.3901dupA has been reported in the literature in at least one individual affected with Familial Adenomatous Polyposis (Gismondi_1997). These report(s) do not provide unequivocal conclusions about association of the variant with Familial Adenomatous Polyposis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22864938, 9101302). ClinVar contains an entry for this variant (Variation ID: 433656). Based on the evidence outlined above, the variant was classified as pathogenic. -
Gastric cancer;C0346629:Colorectal cancer;C1851124:Desmoid disease, hereditary;C2239176:Hepatocellular carcinoma;C2713442:Familial adenomatous polyposis 1;C4749917:Gastric adenocarcinoma and proximal polyposis of the stomach Pathogenic:1
- -
Carcinoma of colon Pathogenic:1
The APC p.Thr1301AsnfsX14 variant was identified in the literature as a somatic mutation in the tumour of a patient with sporadic colorectal cancer (Christie 2013). The variant was also identified in the HGMD, UMD (1X), the InSiGHT Colon Cancer database and the COSMIC database (2X). The p.Thr1301AsnfsX14 duplication variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 1301 and leads to a premature stop codon 14 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the APC gene are an established mechanism of disease in familial adenomatous polyposis and is the type of variant expected to cause the disorder. This variant occurs in the last exon of the gene and stop codon or nonsense mutations in this region may not be subjected to nonsense mediated RNA decay, although further study would be required to validate this hypothesis and it is currently not possible to determine whether or not this might influence the severity of the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic. -
Familial adenomatous polyposis 1 Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9101302, 23085758, 23159591, 22864938) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at